Quartz·1 min read·medium
Merck won FDA approval for the first cholesterol pill to rival powerful injectables
✦AI Summary
Merck has received FDA approval for Lipfendra, a once-daily pill that significantly reduces LDL cholesterol. This new medication serves as a competitive alternative to existing injectable cholesterol treatments.
Lipfendra, a once-daily pill, reduced LDL cholesterol by up to 59% in late-stage trials, rivaling existing injectable treatments
healthbusiness
✦
Get the full story
Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.
Create free accountAlready have an account? Sign in